1 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 [1] 113 💬 |
2 |
Alirocumab sar236553 (regn727) |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
3 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
4 |
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab |
Abatacept |
[4] D02596 D02596, D02994 D02994, D03203 D03203, D10161 D10161 💬 |
CD80 [4] CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection [24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
5 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
6 |
Fluoxetine hydrochloride |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
7 |
Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 [1] 229 💬 |
8 |
Gm-csf [leukine (sargramostim)] |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 [1] 229 💬 |
9 |
Gz/sar402671 |
- |
- |
- |
- |
006 [2] 6 , 19 💬 |
10 |
Gz402671 / sar402671 |
- |
- |
- |
- |
019 [1] 19 💬 |
11 |
Isatuximab |
Isatuximab |
[1] D11050 D11050 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 [2] 28, 61 💬 |
12 |
Isatuximab sar650984 |
Isatuximab |
[1] D11050 D11050 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
061 [1] 61 💬 |
13 |
Lademirsen (sar339375) |
- |
- |
- |
- |
218 [1] 218 💬 |
14 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 [1] 301 💬 |
15 |
Regn475/sar164877 |
- |
- |
- |
- |
298 [1] 298 💬 |
16 |
Sar |
- |
- |
- |
- |
046 [1] 46 💬 |
17 |
Sar100842 |
- |
- |
- |
- |
051 [1] 51 💬 |
18 |
Sar113244 |
- |
- |
- |
- |
049 [1] 49 💬 |
19 |
Sar153191 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [4] 41, 46, 107, 271 💬 |
20 |
Sar153191 (regn88) |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 107 💬 |
21 |
Sar156597 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
22 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 [1] 51 💬 |
23 |
Sar231893 |
- |
- |
- |
- |
051 [2] 51, 160 💬 |
24 |
Sar236553 |
- |
- |
- |
- |
079 [1] 79 💬 |
25 |
Sar339658 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
26 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 [3] 6 , 19, 67 💬 |
27 |
Sar421869 |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
28 |
Sar422459 |
- |
- |
- |
- |
301 [1] 301 💬 |
29 |
Sar441344 |
- |
- |
- |
- |
053 [1] 53 💬 |
30 |
Sar442168 |
- |
- |
- |
- |
013 [1] 13 💬 |
31 |
Saracatinab |
- |
- |
- |
- |
085 [1] 85 💬 |
32 |
Saracatinib |
Saracatinib |
[1] D09664 D09664 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 [3] 6 , 89, 272 💬 |
33 |
Saracatinib difumarate |
Saracatinib |
[1] D09664 D09664 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
272 [1] 272 💬 |
34 |
Sarcosine |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
35 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
36 |
Sargramostim |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 [7] 6 , 28, 60, 62, 96, 229, 285 💬 |
37 |
Sargramostim (leukine) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 [1] 96 💬 |
38 |
Sarilumab |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [5] 41, 46, 84, 107, 271 💬 |
39 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara] |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
40 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
084 [1] 84 💬 |
41 |
Sarilumab sar153191 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [1] 41 💬 |
42 |
Sarilumab sar153191 (regn88) |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 107 💬 |
43 |
Sarizotan |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
44 |
Sarizotan hc1 |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
45 |
Sarizotan hcl |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
46 |
Sarizotan hydrochloride |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
47 |
Saroglitazar |
Saroglitazar |
- |
- |
- |
093 [1] 93 💬 |
48 |
Saroglitazar magnesium 2 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
49 |
Saroglitazar magnesium 4 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
50 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
[7] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR [4] GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction [9] Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
51 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
52 |
Venglustat (gz/sar402671) |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
53 |
Venglustat gz/sar402671 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
067 [1] 67 💬 |